New Drug Has Promise for Treating Diffuse Intrinsic Pontine Glioma and Fibrodysplasia Ossificans Progressiva

Diffuse Intrinsic Pontine Glioma Diffuse intrinsic pontine glioma (DIPG) is a rare form of childhood brain cancer that has a 100% mortality rate. Children diagnosed with DIPG only typically live…

Continue Reading New Drug Has Promise for Treating Diffuse Intrinsic Pontine Glioma and Fibrodysplasia Ossificans Progressiva

New Research With the Potential to Alleviate Symptoms of Parkinson’s, Alzheimer’s and Charcot-Marie-Tooth Disorders

  A recent article in the neuroscience section of the Medical Express reports the results of a study conducted by researchers in the Charcot-Marie-Tooth/Hereditary Neuropathy Center at internationally acclaimed Cedars-Sinai.…

Continue Reading New Research With the Potential to Alleviate Symptoms of Parkinson’s, Alzheimer’s and Charcot-Marie-Tooth Disorders
Findings From Latest Trial Could Herald Progress in Developing a Treatment for Huntington’s Disease
470906 / Pixabay

Findings From Latest Trial Could Herald Progress in Developing a Treatment for Huntington’s Disease

According to a story from Biopharma Dive, an investigational therapy for Huntington's disease that is in development could be the first step in the implementation of the first-ever disease modifying…

Continue Reading Findings From Latest Trial Could Herald Progress in Developing a Treatment for Huntington’s Disease
Clinical Trial for Experimental Centronuclear Myopathy Drug Given the Green Light
WikimediaImages / Pixabay

Clinical Trial for Experimental Centronuclear Myopathy Drug Given the Green Light

According to a story from BioSpace, the drug development company Dynacure recently released an announcement in which the company stated that its application for a Phase 1/2 clinical trial had…

Continue Reading Clinical Trial for Experimental Centronuclear Myopathy Drug Given the Green Light

First Ever Treatment for Transthyretin-Mediated Amyloidosis Cardiomyopathy Approved by FDA

Transthyretin-Mediated Amyloidosis Cardiomyopathy The FDA has just approved the very first treatment for hereditary or wild-type transthyretin-mediated amyloidosis cardiomyopathy (ATTR-CM).  ATTR-CM is a rare disease that occurs when amyloids, an…

Continue Reading First Ever Treatment for Transthyretin-Mediated Amyloidosis Cardiomyopathy Approved by FDA
New Data on the Difference Between Plasma Cell Myeloma and Smoldering Myeloma Has Treatment Implications
ColiN00B / Pixabay

New Data on the Difference Between Plasma Cell Myeloma and Smoldering Myeloma Has Treatment Implications

A recent report that was published in the Swiss Medical Weekly outlines data gathered by a Swiss panel of experts on plasma cell myeloma. The report offers an update and…

Continue Reading New Data on the Difference Between Plasma Cell Myeloma and Smoldering Myeloma Has Treatment Implications
Could This Experimental Therapy be a Breakthrough for Genetic Amyotrophic Lateral Sclerosis?
NeuPaddy / Pixabay

Could This Experimental Therapy be a Breakthrough for Genetic Amyotrophic Lateral Sclerosis?

According to a story from fox43.com, an experimental therapy for the genetic form of amyotrophic lateral sclerosis (ALS) has been termed "game changing." A study that will soon be presented…

Continue Reading Could This Experimental Therapy be a Breakthrough for Genetic Amyotrophic Lateral Sclerosis?

Study Shows New Blood Test can Accurately Diagnose Chronic Fatigue Syndrome

Chronic Fatigue Syndrome Chronic fatigue syndrome (CFS) is a rare disease which causes, most notably, persistent fatigue that doesn't improve with rest. It is also sometimes referred to as myalgic…

Continue Reading Study Shows New Blood Test can Accurately Diagnose Chronic Fatigue Syndrome

Vascular Ehlers-Danlos Syndrome Patient Data Released Following Study

According to a story from globenewswire.com, the pharmaceutical company Acer Therapeutics recently announced the release of data from a long-term observational study of patients with vascular Ehlers-Danlos syndrome (vEDS). All…

Continue Reading Vascular Ehlers-Danlos Syndrome Patient Data Released Following Study

Researchers Believe Lithium May be Key to Developing a Drug for Limb Girdle Muscular Dystrophy

The News Hub at Washington State University recently carried an article describing initial success by researchers towards developing a drug for a rare form of muscular dystrophy. Several thousand people…

Continue Reading Researchers Believe Lithium May be Key to Developing a Drug for Limb Girdle Muscular Dystrophy
Study Finds That Older Female Ankylosing Spondylitis Patients with Dyslipidemia are at Greater Risk of Osteoporosis
rawpixel / Pixabay

Study Finds That Older Female Ankylosing Spondylitis Patients with Dyslipidemia are at Greater Risk of Osteoporosis

According to a story from Ankylosing Spondylitis News, a recent study has reaffirmed the understanding that patients with ankylosing spondylitis, a rare form of inflammatory disease that affects the joints…

Continue Reading Study Finds That Older Female Ankylosing Spondylitis Patients with Dyslipidemia are at Greater Risk of Osteoporosis
Study Finds Similar Rates of Lambert-Eaton Myasthenic Syndrome (LEMS) in Europe and the US
geralt / Pixabay

Study Finds Similar Rates of Lambert-Eaton Myasthenic Syndrome (LEMS) in Europe and the US

According to a story from Lambert-Eaton News, a recent large scale study using data from the Veterans Affairs has determined that the prevalence of Lambert-Eaton myasthenic syndrome (LEMS) is similar…

Continue Reading Study Finds Similar Rates of Lambert-Eaton Myasthenic Syndrome (LEMS) in Europe and the US